The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001110792.2(MECP2):c.1466G>C (p.Ser489Thr)

CA170245

143475 (ClinVar)

Gene: MECP2
Condition: Rett syndrome
Inheritance Mode: X-linked inheritance
UUID: 32d53fd8-0652-4c83-ba6a-b7a791fb3b20
Approved on: 2024-08-30
Published on: 2024-11-15

HGVS expressions

NM_001110792.2:c.1466G>C
NM_001110792.2(MECP2):c.1466G>C (p.Ser489Thr)
NC_000023.11:g.154030398C>G
CM000685.2:g.154030398C>G
NC_000023.10:g.153295849C>G
CM000685.1:g.153295849C>G
NC_000023.9:g.152949043C>G
NG_007107.2:g.111730G>C
NG_007107.3:g.111706G>C
ENST00000303391.11:c.1430G>C
ENST00000453960.7:c.1466G>C
ENST00000303391.10:c.1430G>C
ENST00000453960.6:c.1466G>C
ENST00000619732.4:c.1430G>C
ENST00000628176.2:c.*802G>C
NM_001110792.1:c.1466G>C
NM_001316337.1:c.1151G>C
NM_004992.3:c.1430G>C
NM_001316337.2:c.1151G>C
NM_001369391.2:c.1151G>C
NM_001369392.2:c.1151G>C
NM_001369393.2:c.1151G>C
NM_001369394.1:c.1151G>C
NM_001369394.2:c.1151G>C
NM_001386137.1:c.761G>C
NM_001386138.1:c.761G>C
NM_001386139.1:c.761G>C
NM_004992.4:c.1430G>C
More

Likely Benign

Met criteria codes 1
BS2
Not Met criteria codes 4
BA1 PM2 BS1 BP2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Rett and Angelman-like Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for MECP2 Version 3.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The p.Ser477Thr (NM_004992.3) variant is observed in at least 2 unaffected individuals (PMID: 12655490) (BS2). The p.Ser477Thr variant is observed in the MECP2 gene where a second pathogenic variant in the same gene is present in the patient (PMID 12655490); however, it is unknown if the variants are in cis or trans (BP5 - not met). The highest population minor allele frequency of the p.Ser477Thr variant in MECP2 (NM_004992.3) in gnomAD v4.1 is 0.000008933 in European (non-Finnish) population (not sufficient to meet BA1, BS1, or PM2 criteria). In the absence of conflicting evidence, this is sufficient evidence to classify as likely benign based on the specifications defined by the ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel. In summary, the p.Ser477Thr variant in MECP2 (NM_004992.3) is classified as likely benign for Rett syndrome based on the ACMG/AMP criteria (BS2).
Met criteria codes
BS2
The p.Ser477Thr variant is observed in at least 2 unaffected individuals (PMID 12655490) (BS2).
Not Met criteria codes
BA1
The highest population minor allele frequency of the p.Ser477Thr variant in MECP2 (NM_004992.3) in gnomAD v4.1 is 0.000008933 in European (non-Finnish) population (not sufficient to meet BA1 criteria).
PM2
The highest population minor allele frequency of the p.Ser477Thr variant in MECP2 (NM_004992.3) in gnomAD v4.1 is 0.000008933 in European (non-Finnish) population (not sufficient to meet PM2 criteria).
BS1
The highest population minor allele frequency of the p.Ser477Thr variant in MECP2 (NM_004992.3) in gnomAD v4.1 is 0.000008933 in European (non-Finnish) population (not sufficient to meet BS1 criteria).
BP2
The p.Ser477Thr variant is observed in the MECP2 gene where a second pathogenic variant in the same gene is present in the patient (PMID 12655490); however, it is unknown if the variants are in cis or trans (BP2_not_met).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.